9. STOCK-BASED COMPENSATION (Details - Option activity) (Options, USD $)
|
3 Months Ended |
---|---|
Mar. 31, 2015
|
|
Options
|
|
Share-based compensation activity | |
Options outstanding, beginning balance |
6,470,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Options outstanding, granted | |
Options outstanding, exercised | |
Options outstanding, forfeited |
(80,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Options outstanding, expired | |
Options outstanding, ending balance |
6,390,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Options outstanding, exercisable |
3,530,250us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Options outstanding, unvested |
2,859,750us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Options outstanding, vested or expected to vest |
6,390,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average exercise price, beginning balance |
$ 2.70us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average exercise price, forfeited |
$ 2.82us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average exercise price, ending balance |
$ 2.70us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average exercise price, exercisable |
$ 2.66us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average exercise price, unvested |
$ 2.74us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average exercise price, vested or expected to vest |
$ 2.70us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Weighted average remaining contract term, ending term | 9 years 7 months 21 days |
Weighted average remaining contract term, exercisable | 9 years 8 months 5 days |
Weighted average remaining contract term, unvested | 9 years 7 months 2 days |
Weighted average remaining contract term, vested or expected to vest | 9 years 7 months 21 days |
Aggregate intrinsic value, ending balance |
$ 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Aggregate intrinsic value, exercisable |
0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Aggregate intrinsic value, unvested |
0canv_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1Unvested / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
Aggregate intrinsic value, vested or expected to vest |
$ 0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue / us-gaap_StatementEquityComponentsAxis = us-gaap_StockOptionMember |
X | ||||||||||
- Definition
Aggregate intrinsic value, unvested No definition available.
|
X | ||||||||||
- Definition
Weighted average remaining contract term, unvested No definition available.
|
X | ||||||||||
- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition
Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
As of the balance sheet date, the weighted-average exercise price (at which grantees can acquire the shares reserved for issuance) for exercisable stock options that are fully vested or expected to vest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. No definition available.
|
X | ||||||||||
- Definition
Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|